A perspective on targeting inflammation and cytokine actions in atherosclerosis

Chan, Yee-Hung and Ramji, Dipak ORCID: https://orcid.org/0000-0002-6419-5578 2020. A perspective on targeting inflammation and cytokine actions in atherosclerosis. Future Medicinal Chemistry 12 (7) , pp. 613-626. 10.4155/fmc-2019-0301

PDF - Accepted Post-Print Version Download (528kB)

Abstract

Atherosclerosis, a chronic inflammatory disorder of the vasculature that results in cardiovascular disease, continues to pose a significant health and economic burden on modern society. Whilst inflammation has generally been accepted as the key driver of all stages of the disease, it was not until recently that inhibition of a specific proinflammatory cytokine (IL-1β) yielded successful results in the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study trial. This article offers a perspective on targeting inflammation for atherosclerosis, focusing on results of recent Phase III clinical trials, and discusses other potential candidates together with future challenges and prospects.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences
Publisher:	Future Science Ltd
ISSN:	1756-8919
Date of First Compliant Deposit:	22 January 2020
Date of Acceptance:	15 January 2020
Last Modified:	30 Nov 2024 05:30
URI:	https://orca.cardiff.ac.uk/id/eprint/128932

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item